Loading...
Phase I Study of Adenovirus p53 Administered by Bronchoalveolar Lavage in Patients With Bronchioloalveolar Cell Lung Carcinoma: ECOG 6597
PURPOSE: This pilot phase I trial evaluated the safety and maximum-tolerated dose of p53 gene transfer using an adenovirus vector (Ad-p53) delivered via bronchoalveolar lavage (BAL) to patients with bronchioloalveolar lung carcinoma (BAC). PATIENTS AND METHODS: Patients were initially administered t...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society of Clinical Oncology
2008
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2654378/ https://ncbi.nlm.nih.gov/pubmed/18757331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.15.6927 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|